| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |